Sep 05 2024
A study published recently in the journal ACR Open Rheumatology reveals that a significant number of patients with rheumatic conditions in the U.S. and Canada are substituting medical marijuana for traditional medications. Conducted by researchers from the University at Buffalo, McGill University, and the University of Michigan Medical School, the study analyzed responses from 763 …
Sep 05 2024
A groundbreaking study published in the per reviewed journal Neurotherapeutics shows that a combination of tetrahydrocannabinol (THC) and cannabidiol (CBD) may offer new hope for treating Alzheimer’s disease (AD). “A combination of Δ9-tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD) at non-psychoactive doses was previously demonstrated to reduce cognitive decline in APP/PS1 mice, an animal model of Alzheimer’s …
Sep 05 2024
A new study published in the journal Nature Communications reveals that cannabidiol (CBD) may offer a breakthrough in treating primary mitochondrial diseases (MD), a group of untreatable disorders caused by mutations in energy-producing genes. The research specifically focuses on Leigh syndrome (LS), the most common pediatric MD, which is marked by progressive neuromuscular impairment and …
Sep 03 2024
A study published in the recent issue of the journal Cancer Immunology Research suggests that cannabidiol (CBD) may enhance the effectiveness of atezolizumab, a drug commonly used in treating triple-negative breast cancer (TNBC). The study, which was published online ahead of print by the National Library of Medicine, highlights the potential for CBD to be …
Sep 01 2024
A new study published in the journal Talanta highlights the development of a novel microfluidic paper-based analytical device (μCD-PAD) that can simultaneously detect ethanol and tetrahydrocannabinol (THC) in saliva, offering what researchers describe as a non-invasive, rapid, and cost-effective method for on-site analysis. For the study, which was also published online by the US National …
Aug 31 2024
A new study from researchers at Khon Kaen University in Thailand has revealed that cannabidiol (CBD) could be a powerful weapon against gemcitabine-resistant cholangiocarcinoma (CCA), a particularly challenging form of bile duct cancer. Published in the journal BMC Complementary Medicine and Therapies, the study highlights CBD’s potential to overcome drug resistance in CCA through mechanisms …
Aug 31 2024
According to the results of a newly published study, “psilocybin is highly effective in reducing depressive symptoms severity” among patients with major depressive disorder and treatment-resistant depression. Published in the journal Brain Sciences, the study is titled Comparison between Single-Dose and Two-Dose Psilocybin Administration in the Treatment of Major Depression: A Systematic Review and Meta-Analysis …
Aug 30 2024
Researchers at the University of Southern Santa Catarina in Brazil have conducted a comprehensive review, revealing the potential of “classic psychedelics” such as LSD, psilocybin, and ayahuasca in treating alcohol use disorder (AUD). The study, published in the journal Progress in Neuro-Psychopharmacology and Biological Psychiatry, highlights the pharmacotherapeutic effects of these substances, particularly in cases …
Aug 29 2024
A significant majority of nursing students believe that patients should have legal access to medical marijuana, yet many report a lack of adequate training on the subject during their education, according to a recent survey published in the journal Nurse Practitioner. Researchers from Simmons College in Boston conducted a survey of over 100 nurse practitioner …
Aug 29 2024
The past-year use of cannabis and psychedelics (referred to in the study as hallucinogens) stayed at historically high levels in 2023 among adults aged 19 to 30 and 35 to 50, according to the latest findings from the Monitoring the Future survey. In contrast, past-year use of cigarettes remained at historically low levels in both adult groups. …
